Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tscan Therapeutics, Inc.

1.81
+0.04002.26%
Post-market: 1.840.0300+1.66%19:52 EDT
Volume:304.58K
Turnover:549.15K
Market Cap:102.43M
PE:-0.78
High:1.86
Open:1.79
Low:1.76
Close:1.77
Loading ...
Jul 28, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 22, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 20, 2021

Major Issues Report

8-K - Current report
Jul 16, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jul 16, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jul 14, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 13, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 13, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 12, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 14, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 05, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Apr 30, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 30, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 30, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Apr 23, 2021

Correspondence

CORRESP [Cover] - Correspondence
Apr 23, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 05, 2018

Delisting

Jun 04, 2018

Correspondence

Jun 04, 2018

Correspondence